Harbor Health Plan Formulary

Size: px
Start display at page:

Download "Harbor Health Plan Formulary"

Transcription

1 2018 Harbor Health Plan Formulary Version 13; Effective: 7/1/2018

2 Introduction... 5 The SentinelRx Pharmacy and Therapeutics Committee (P&T)... 5 Notice... 5 Preface... 5 Product Selection Criteria... 5 Formulary Components... 5 Generic Substitution... 5 Covered Medications without Authorization... 5 Non-Covered Benefits... 6 Prior Authorization... 6 Step Therapy... 6 Specialty Medications... 6 Quantity Limits... 6 Benefit Exception... 6 Pharmacy Benefit Management... 6 Step Therapy Information... 7 Prior Authorization Information Acne Therapy Analgesic, Anti-inflammatory or Antipyretic - Non-Narcotic Analgesics - Narcotic Androgen-Anabolic Angina Therapy Anorectal - Glucocorticoids Anterior Pituitary Hormones and Hormone Antagonists Antianxiety Agents Antiarrhythmics Antibacterial Agents Anticoagulants Antidepressants Antidiarrheals Antiemetics Antifungals Antihistamines Antihyperlipidemics Antihypertensive Therapy Agents Antineoplastic - Alkylating Agents Antineoplastic - Antimetabolites Antineoplastic - Hedgehog Pathway Inhibitor Antineoplastic - Hormone/Hormone Antagonist Agents Antineoplastic - Immunomodulators Antineoplastic - Retinoids and Retinoid Receptor Agonists Antineoplastic - Systemic Enzyme Inhibitors Antineoplastic - Topoisomerase Inhibitors Antiparasitics Antiparkinson Therapy Antiprotozoal-Antibacterial Agents Antipsychotics (Neuroleptics) Antivirals Appetite Stimulants Asthma/COPD Therapy Agents Beta Adrenergic Blockers Calcium and Bone Metabolism Regulators Calcium Channel Blockers and Combinations Cardiac Inotropes Cardiovascular Sympathomimetics and Combinations Chelating Agents Chemotherapy Rescue-Antidote Agents CNS Stimulants Cognitive Disorder Therapy - Antidementia Colonic Acidifier (Ammonia Inhibitor) Contraceptives Injectable Contraceptives Intravaginal Contraceptives Oral Contraceptives Transdermal Corticosteroids Cystic Fibrosis Therapy Agents

3 Dental-Periodontal Products Dermatological - Anti-infectives Dermatological - Antineoplastic or Premalignant Lesions Dermatological - Antiparasitics and Combinations Dermatological - Antiperspirants and Deodorants Dermatological - Antipsoriatics Dermatological - Antiseborrheic Products and Combinations Dermatological - Burn Products Dermatological - Emollients and Combinations Dermatological - Enzymes and Combinations Dermatological - Glucocorticoids and Combinations Dermatological - Immunomodulating Agents Dermatological - Immunosuppressive Agents Dermatological - Keratolytics-Antimitotics Dermatological - NSAID s Dermatological - Rosacea Therapy Dermatological - Topical Local Anesthetics and Combinations Diabetic Therapy Digestive Aids Diuretics Electrolyte Depleters - Ion Exchange Resin Emergency Contraceptives and Combinations Estrogens and Combinations Gallstone Solubilizing (Litholysis) Agents and Combinations Gastrointestinal Antispasmodics Gastrointestinal Prokinetic Agents General Anesthetics Gout - Acute Therapy Gout and Hyperuricemia Combination Drugs Hematopoietic Agents Hematorheologic Agents Hepatic Hormones (Hormones Secreted by the Liver) Hyperuricemia Therapy Immunosuppressive - Calcineurin Inhibitors Immunosuppressive - Inosine Monophosphate Dehydrogenase Inhibitors Immunosuppressive - Mammalian Target of Rapamycin (mtor) Inhibitors Immunosuppressive - Purine Analogs Inflammatory Bowel Agents Interstitial Cystitis Agents Laxatives Medical Supplies and DME - Contraceptives Medical Supplies and DME - Diabetic Supplies Medical Supplies and DME - Respiratory Therapy Migraine Therapy Minerals and Electrolytes Misc Anti-Infectives and Combinations Mouth and Throat - Anti-infectives Mouth and Throat - Glucocorticoids Mouth and Throat - Local Anesthetics Mouth and Throat - Xerostomia Therapy Mucolytics Multiple Sclerosis Agent - Interferons Multiple Sclerosis Agent - Others Multiple Sclerosis Agent - Potassium Channel Blocker Multiple Sclerosis Agent - Sphingosine 1-phosphate receptor modulator Musculoskeletal Therapy Agents Nasal Preparations Neuromuscular Therapy Agents Ophthalmic - Anti-allergy Ophthalmic - Anti-infectives Ophthalmic - Anti-inflammatory Ophthalmic - Decongestants and Combinations Ophthalmic - Intraocular Pressure Reducing Agents Ophthalmic - Local Anesthetics and Combinations Ophthalmic - Mydriatics and Cycloplegics Ophthalmic Combinations Opiate/Narcotic Reversal Agents - Opiate Antagonists

4 Otic - Anti-infectives Otic - Glucocorticoids Otic Combinations Oxytocics Passive Immunizing Agents Peptic Ulcer Therapy Pharmaceutical Adjuvants Phosphate Binders Platelet Aggregation Inhibitors and Combinations Posterior Pituitary Hormones Progestins Prolactin Inhibitors Prostatic Hypertrophy Agents Sickle Cell Anemia Agents Smoking Deterrents and Combinations Thyroid Therapy Urinary Analgesics Urinary Anti-infectives Urinary Antispasmodics Urinary ph Modifiers Urinary Retention Therapy Vaccines Vaginal Anti-infectives Vaginal Estrogens Vitamin Combinations Vitamins Acne Therapy Analgesic, Anti-inflammatory or Antipyretic - Non-Narcotic Antacids and Combinations Antidiarrheals Antiemetics Antihistamines Antihyperlipidemics Antiparasitics Artificial Tears and Lubricants Bulk Chemicals Contraceptives Intravaginal Dental-Periodontal Products Dermatological - Anti-infectives Dermatological - Antiparasitics and Combinations Dermatological - Emollients and Combinations Dermatological - Glucocorticoids and Combinations Dermatological - Irritants-Counter-Irritants Dermatological - Topical Local Anesthetics and Combinations Diabetic Therapy Dietary Products Emergency Contraceptives and Combinations Gastrointestinal Antiflatulents and Combinations Laxatives Medical Supplies and DME - Contraceptives Medical Supplies and DME - Diabetic Supplies Medical Supplies and DME - Respiratory Therapy Medical Supply, FDB Superset Minerals and Electrolytes Nasal Preparations Ophthalmic - Anti-allergy Ophthalmic - Decongestants and Combinations Ophthalmic - Hyperosmolar Agents Peptic Ulcer Therapy Sedative-Hypnotics Smoking Deterrents and Combinations Urinary Antispasmodics Urinary ph Modifiers Vaginal Anti-infectives Vitamin Combinations Vitamins

5 Introduction Harbor Health Plan is pleased to provide an updated 2018 Medicaid Formulary as a reference and informational tool for physicians, pharmacists and patients. The Harbor Formulary is designed to assist practitioners in selecting clinically appropriate and cost-effective products for their patients. The SentinelRx Pharmacy and Therapeutics Committee (P&T) The medications on this formulary have been reviewed by the SentinelRx P&T Committee. The Committee includes physicians, pharmacists and health professionals. The clinical information within the formulary is primarily derived from medical literature and is reviewed and approved by the P&T Committee. Notice The information contained in this formulary is provided by Harbor, solely for the convenience of medical providers. This formulary is not intended to be a substitute for the knowledge, expertise, skill and judgment of the medical provider in their choice of prescription drugs. Harbor Health Plan assumes no responsibility for the actions or omissions of any medical provider based upon reliance, in whole or in part, on the information contained herein. The medical provider should consult the drug manufacturer s product literature or standard references for more detailed information. Preface The Harbor formulary is organized by sections. Each section includes therapeutic groups identified by either drug class or disease state. Products are listed by generic name. Brand and common names are included as a reference to assist in product recognition. Harbor will not cover prescription drugs that are prescribed for experimental, investigational or non FDA approved indications, dosages, or routes of administration. Harbor does not cover any medication excluded by Michigan Medicaid. Product Selection Criteria The SentinelRx P&T Committee considers clinical information on new to market drugs that are typically included in an outpatient pharmacy benefit. The primary goal of the SentinelRx P&T Committee is to preserve and evaluate the Harbor formulary based upon an objective analysis of the safety, efficacy, approved indications, adverse effects, contraindications, patient administration/compliance considerations and cost effectiveness. When a new drug is considered for formulary inclusion, it will be reviewed relative to similar drugs currently included in the Harbor Formulary. Formulary decisions are communicated quarterly on the Harbor Health Plan website. Formulary Components The Harbor Formulary contains the following components: Covered medications without authorization, medications that must meet Step Therapy Protocol, medications that require Prior Authorization, Specialty medications and medications that are subject to Quantity Limits. Members will not be charged a co-pay when Harbor covers a medication. Generic Substitution Harbor is a mandatory generic plan. The brand and common names listed in the formulary are for reference only. Generic medication will be dispensed where available. Covered Medications without Authorization Harbor covers many medications without any authorization required. These medications include many prescription and over-the-counter medications(when ordered by a physician). 5

6 Non-Covered Benefits The following categories are not covered benefits: Medications used for cosmetic purposes, to promote fertility, for sexual dysfunction, for experimental or investigational purposes, or medications that are not licensed for use in the United States. Prior Authorization Drugs indicated with "PA" require Prior Authorization for coverage. Details of the PA criteria are listed next to the drug name. Please call the SentinelRx Help Desk at or fax a completed Prior Authorization form to Non-Urgent requests are reviewed within 14 days. Urgent requests must be accompanied by pertinent clinical information and are reviewed within 72 hours. Step Therapy Drugs indicated with a "ST" require Step Therapy for coverage. The required step is listed next to the drug name. Specialty Medications All specialty medications noted as "SP" are handled by SentinelRx. To order a specialty medication by fax, send the prescription and a completed prior authorization form to or call SentinelRx s Help Desk at Quantity Limits Drugs indicated with a "" have a set quantity limit imposed. These limits are based on FDA recommended dosing guidelines. The quantity limit is listed next to the drug name. All medications are subject to a maximum of 30 days per prescription. Benefit Exception The process for requesting non formulary medication(s) requires faxing of a completed Formulary Exception form indicating the request for an exception to the formulary. This request will need to include pertinent clinical documentation showing trial and failure of all formulary agents. It should also contain information showing the medication is the standard of care for the indication provided (Peer reviewed journal articles may be required). Please call the SentinelRx Help Desk at or fax a completed Formulary Exception form to Pharmacy Benefit Management Harbor Health Plan utilizes SentinelRx to manage each member s pharmacy benefit. SentinelRx provides Harbor with a pharmacy network, pharmacy claims management services, and claims adjudication. SentinelRx s Help Desk can be contacted at

7 Step Therapy Information Angina Therapy NITROGLYCERIN LINGUAL 0.4 MG NITROGLYCERIN ST Requires trial and failure of Nitroglycerin sublingual tablets;must show trial and failure of Nitroglycerin tablets Antiemetics GRANISETRON HCL 1 MG TABLET GRANISETRON HCL,ST Requires trial and failure of one of the following step 1 agents, Ondansetron HCL or Ondansetron ODT, within the last 180 days. Dermatological - Antiparasitics and Combinations MALATHION 0.5% LOTION MALATHION,ST Requires trial and failure of OTC Permethrin 1% products within the last 180 days. Immunosuppressive - Inosine Monophosphate Dehydrogenase Inhibitors MYCOPHENOLIC ACID DR 180 MG TB MYCOPHENOLIC ACID ST Requires trial and failure Mycophenolate within the last 180 days. MYCOPHENOLIC ACID DR 360 MG TB MYCOPHENOLIC ACID ST Requires trial and failure Mycophenolate within the last 180 days. Inflammatory Bowel Agents APRISO ER GRAM CAPSULE APRISO ST Requires trial and failure of one of the following step 1 agents, Balsalazide Disodium or Sulfasalazine, within the last 180 days. DELZICOL DR 400 MG CAPSULE DELZICOL ST Requires trial and failure of one of the following step 1 agents, Balsalazide Disodium or Sulfasalazine, within the last 180 days. MESALAMINE 800 MG DR TABLET MESALAMINE,ST Requires trial and failure of one of the following step 2 agents, Apriso and Delzicol, within the last 180 days. PENTASA 250 MG CAPSULE PENTASA,ST Requires trial and failure of one of the following step 2 agents, Apriso and Delzicol, within the last 180 days. PENTASA 500 MG CAPSULE PENTASA,ST Requires trial and failure of one of the following step 2 agents, Apriso and Delzicol, within the last 180 days. Migraine Therapy ZOLMITRIPTAN 2.5 MG ODT ZOLMITRIPTAN ODT,ST Requires trial and failure of two of the following step 1 agents, Naratriptan, Rizatriptan, or Sumatriptan, within the last 180 days. 7

8 Step Therapy Information Migraine Therapy ZOLMITRIPTAN 2.5 MG TABLET ZOLMITRIPTAN,ST Requires trial and failure of OTC Permethrin 1% products within the last 180 days.;requires trial and failure of two of the following step 1 agents, Naratriptan, Rizatriptan, or Sumatriptan, within the last 180 days. ZOLMITRIPTAN 5 MG ODT ZOLMITRIPTAN ODT,ST Requires trial and failure of two of the following step 1 agents, Naratriptan, Rizatriptan, or Sumatriptan, within the last 180 days. ZOLMITRIPTAN 5 MG TABLET ZOLMITRIPTAN,ST Requires trial and failure of two of the following step 1 agents, Naratriptan, Rizatriptan, or Sumatriptan, within the last 180 days. Peptic Ulcer Therapy LANSOPRAZOLE DR 15 MG CAPSULE LANSOPRAZOLE,ST Requires trial and failure of two of the following step 1 agents, Omeprazole and Pantoprazole, within the last 180 days. LANSOPRAZOLE DR 30 MG CAPSULE LANSOPRAZOLE,ST Requires trial and failure of two of the following step 1 agents, Omeprazole and Pantoprazole, within the last 180 days. Urinary Antispasmodics TOLTERODINE TART ER 2 MG CAP TOLTERODINE TARTRATE ER,ST Requires trial and failure of Oxybutynin within the last 180 days. TOLTERODINE TART ER 4 MG CAP TOLTERODINE TARTRATE ER,ST Requires trial and failure of Oxybutynin within the last 180 days. TOLTERODINE TARTRATE 1 MG TAB TOLTERODINE TARTRATE,ST Requires trial and failure of Oxybutynin within the last 180 days. TOLTERODINE TARTRATE 2 MG TAB TOLTERODINE TARTRATE,ST Requires trial and failure of Oxybutynin within the last 180 days. TROSPIUM CHLORIDE 20 MG TABLET TROSPIUM CHLORIDE,ST Requires trial and failure of Oxybutynin within the last 180 days. Peptic Ulcer Therapy CVS LANSOPRAZOLE DR 15 MG CAP LANSOPRAZOLE,ST Requires trial and failure of two of the following step 1 agents, Omeprazole and Pantoprazole, within the last 180 days. EQ LANSOPRAZOLE DR 15 MG CAP LANSOPRAZOLE,ST Requires trial and failure of two of the following step 1 agents, Omeprazole and Pantoprazole, within the last 180 days. HM LANSOPRAZOLE DR 15 MG CAP LANSOPRAZOLE,ST Requires trial and failure of two of the following step 1 agents, Omeprazole and Pantoprazole, within the last 180 days. LANSOPRAZOLE DR 15 MG CAPSULE LANSOPRAZOLE,ST Requires trial and failure of two of the following step 1 agents, Omeprazole and Pantoprazole, within the last 180 days. 8

9 Step Therapy Information Peptic Ulcer Therapy NEXIUM 24HR 20 MG CAPSULE NEXIUM 24HR,ST Trial and Failure of omeprazole; limited to 60 tablets per 30 days.;requires trial and failure of two of the following step 1 agents, Omeprazole and Pantoprazole, within the last 180 days. RA LANSOPRAZOLE DR 15 MG CAP LANSOPRAZOLE,ST Requires trial and failure of two of the following step 1 agents, Omeprazole and Pantoprazole, within the last 180 days. SM LANSOPRAZOLE DR 15 MG CAP LANSOPRAZOLE,ST Requires trial and failure of two of the following step 1 agents, Omeprazole and Pantoprazole, within the last 180 days. 9

10 Prior Authorization Information ZARXIO 300 MCG/0.5 ML SYRINGE ZARXIO PA,SP Prior Authorization Required ZARXIO 480 MCG/0.8 ML SYRINGE ZARXIO PA,SP Prior Authorization Required Acne Therapy CLARAVIS 10 MG CAPSULE CLARAVIS PA, Prior Authorization Required CLARAVIS 20 MG CAPSULE CLARAVIS PA, Prior Authorization Required CLARAVIS 30 MG CAPSULE CLARAVIS PA, Prior Authorization Required CLARAVIS 40 MG CAPSULE CLARAVIS PA, Prior Authorization Required Analgesic, Anti-inflammatory or Antipyretic - Non-Narcotic ENBREL 25 MG KIT ENBREL PA,,SP ENBREL 25 MG/0.5 ML SYRINGE ENBREL PA,,SP ENBREL 50 MG/ML SURECLICK SYR ENBREL SURECLICK PA, ENBREL 50 MG/ML SYRINGE ENBREL PA,,SP HUMIRA 10 MG/0.2 ML SYRINGE HUMIRA PA,,SP OTEZLA 28 DAY STARTER PACK OTEZLA PA,SP Prior Authorization Required OTEZLA 30 MG TABLET OTEZLA PA,SP Prior Authorization Required OTEZLA STARTER PACK OTEZLA PA,SP Prior Authorization Required XATMEP 2.5 MG/ML ORAL SOLUTION XATMEP PA Prior Authorization Required Analgesics - Narcotic FENTANYL 100 MCG/HR PATCH FENTANYL PA, Prior Authorization Required FENTANYL 12 MCG/HR PATCH FENTANYL PA, Prior Authorization Required FENTANYL 25 MCG/HR PATCH FENTANYL PA, Prior Authorization Required FENTANYL 50 MCG/HR PATCH FENTANYL PA, Prior Authorization Required FENTANYL 75 MCG/HR PATCH FENTANYL PA, Prior Authorization Required Angina Therapy RANEXA ER 1,000 MG TABLET RANEXA PA Prior Authorization Required RANEXA ER 500 MG TABLET RANEXA PA Prior Authorization Required Anterior Pituitary Hormones and Hormone Antagonists NORDITROPIN FLEXPRO 10 MG/1.5 NORDITROPIN FLEXPRO PA,SP Prior Authorization Required NORDITROPIN FLEXPRO 15 MG/1.5 NORDITROPIN FLEXPRO PA,SP Prior Authorization Required NORDITROPIN FLEXPRO 30 MG/3 ML NORDITROPIN FLEXPRO PA,SP Prior Authorization Required NORDITROPIN FLEXPRO 5 MG/1.5 NORDITROPIN FLEXPRO PA,SP Prior Authorization Required OCTREOTIDE 1,000 MCG/ML VIAL OCTREOTIDE ACETATE PA,SP Prior Authorization Required OCTREOTIDE ACET 100 MCG/ML VL OCTREOTIDE ACETATE PA,SP Prior Authorization Required OCTREOTIDE ACET 200 MCG/ML VL OCTREOTIDE ACETATE PA,SP Prior Authorization Required OCTREOTIDE ACET 50 MCG/ML VIAL OCTREOTIDE ACETATE PA,SP Prior Authorization Required 10

11 Prior Authorization Information Antibacterial Agents LINEZOLID 100 MG/5 ML SUSP LINEZOLID PA Prior Authorization Required LINEZOLID 600 MG TABLET LINEZOLID PA Prior Authorization Required THALOMID 100 MG CAPSULE THALOMID PA,SP Prior Authorization Required THALOMID 150 MG CAPSULE THALOMID PA,SP Prior Authorization Required THALOMID 200 MG CAPSULE THALOMID PA,SP Prior Authorization Required THALOMID 50 MG CAPSULE THALOMID PA,SP Prior Authorization Required Anticoagulants ELIQUIS 2.5 MG TABLET ELIQUIS PA Prior Authorization Required ELIQUIS 5 MG TABLET ELIQUIS PA Prior Authorization Required ENOXAPARIN 100 MG/ML SYRINGE ENOXAPARIN SODIUM PA Prior Authorization Required ENOXAPARIN 120 MG/0.8 ML SYR ENOXAPARIN SODIUM PA Prior Authorization Required ENOXAPARIN 150 MG/ML SYRINGE ENOXAPARIN SODIUM PA Prior Authorization Required ENOXAPARIN 30 MG/0.3 ML SYR ENOXAPARIN SODIUM PA Prior Authorization Required ENOXAPARIN 40 MG/0.4 ML SYR ENOXAPARIN SODIUM PA Prior Authorization Required ENOXAPARIN 60 MG/0.6 ML SYR ENOXAPARIN SODIUM PA Prior Authorization Required ENOXAPARIN 80 MG/0.8 ML SYR ENOXAPARIN SODIUM PA Prior Authorization Required XARELTO 10 MG TABLET XARELTO PA, XARELTO 15 MG TABLET XARELTO PA, XARELTO 20 MG TABLET XARELTO PA, Antiemetics DRONABINOL 10 MG CAPSULE DRONABINOL PA Prior Authorization Required DRONABINOL 2.5 MG CAPSULE DRONABINOL PA Prior Authorization Required DRONABINOL 5 MG CAPSULE DRONABINOL PA Prior Authorization Required Antihyperlipidemics EZETIMIBE 10 MG TABLET EZETIMIBE PA, Prior Authorization Required OMEGA-3 ETHYL ESTERS 1 GM CAP OMEGA-3 ACID ETHYL ESTERS PA, Prior Authorization Required Antihypertensive Therapy Agents ADCIRCA 20 MG TABLET ADCIRCA PA,SP, Prior Authorization required;must meet Pharmacy Approval Criteria ADEMPAS 0.5 MG TABLET ADEMPAS PA,,SP ADEMPAS 1 MG TABLET ADEMPAS PA,,SP ADEMPAS 1.5 MG TABLET ADEMPAS PA,,SP ADEMPAS 2 MG TABLET ADEMPAS PA,,SP ADEMPAS 2.5 MG TABLET ADEMPAS PA,,SP ENTRESTO 24 MG-26 MG TABLET ENTRESTO PA, ENTRESTO 49 MG-51 MG TABLET ENTRESTO PA, ENTRESTO 97 MG-103 MG TABLET ENTRESTO PA, LETAIRIS 10 MG TABLET LETAIRIS PA,,SP LETAIRIS 5 MG TABLET LETAIRIS PA,,SP 11

12 Prior Authorization Information Antihypertensive Therapy Agents SILDENAFIL 20 MG TABLET SILDENAFIL PA,SP Prior Authorization Required TEKTURNA 150 MG TABLET TEKTURNA PA, TEKTURNA 300 MG TABLET TEKTURNA PA, TEKTURNA HCT MG TAB TEKTURNA HCT PA, TEKTURNA HCT MG TABLET TEKTURNA HCT PA, TEKTURNA HCT MG TAB TEKTURNA HCT PA, TEKTURNA HCT MG TABLET TEKTURNA HCT PA, TRACLEER 125 MG TABLET TRACLEER PA,,SP TRACLEER 32 MG TABLET FOR SUSP TRACLEER PA,SP Prior Authorization Required; Limited to members at or between ages 3 through 12. TRACLEER 62.5 MG TABLET TRACLEER PA,,SP Antineoplastic - Alkylating Agents ALKERAN 2 MG TABLET ALKERAN PA,SP Prior Authorization Required CYCLOPHOSPHAMIDE 25 MG CAPSULE CYCLOPHOSPHAMIDE 50 MG CAPSULE CYCLOPHOSPHAMIDE PA,SP Prior Authorization Required CYCLOPHOSPHAMIDE PA,SP Prior Authorization Required HEXALEN 50 MG CAPSULE HEXALEN PA,SP Prior Authorization Required LEUKERAN 2 MG TABLET LEUKERAN PA,SP Prior Authorization Required MATULANE 50 MG CAPSULE MATULANE PA,SP Prior Authorization Required MYLERAN 2 MG TABLET MYLERAN PA,SP Prior Authorization Required TEMOZOLOMIDE 100 MG CAPSULE TEMOZOLOMIDE PA,SP Prior Authorization Required TEMOZOLOMIDE 140 MG CAPSULE TEMOZOLOMIDE PA,SP Prior Authorization Required TEMOZOLOMIDE 180 MG CAPSULE TEMOZOLOMIDE PA,SP Prior Authorization Required TEMOZOLOMIDE 20 MG CAPSULE TEMOZOLOMIDE PA,SP Prior Authorization Required TEMOZOLOMIDE 250 MG CAPSULE TEMOZOLOMIDE PA,SP Prior Authorization Required TEMOZOLOMIDE 5 MG CAPSULE TEMOZOLOMIDE PA,SP Prior Authorization Required Antineoplastic - Antimetabolites CAPECITABINE 150 MG TABLET CAPECITABINE PA,SP Prior Authorization Required CAPECITABINE 500 MG TABLET CAPECITABINE PA,SP Prior Authorization Required LONSURF 15 MG-6.14 MG TABLET LONSURF PA,SP Prior Authorization Required LONSURF 20 MG-8.19 MG TABLET LONSURF PA,SP Prior Authorization Required TABLOID 40 MG TABLET TABLOID PA,SP Prior Authorization Required Antineoplastic - Hedgehog Pathway Inhibitor ERIVEDGE 150 MG CAPSULE ERIVEDGE PA,,SP ODOMZO 200 MG CAPSULE ODOMZO PA Prior Authorization Required Antineoplastic - Hormone/Hormone Antagonist Agents BICALUTAMIDE 50 MG TABLET BICALUTAMIDE PA Prior Authorization Required 12

13 Prior Authorization Information Antineoplastic - Hormone/Hormone Antagonist Agents EMCYT 140 MG CAPSULE EMCYT PA,SP Restricted to Males Only; Prior Authorization Required EXEMESTANE 25 MG TABLET EXEMESTANE SP FARESTON 60 MG TABLET FARESTON PA,SP Prior Authorization Required FLUTAMIDE 125 MG CAPSULE FLUTAMIDE PA,SP Restricted to Males Only; Prior Authorization Required LEUPROLIDE 2WK 1 MG/0.2 ML KIT LEUPROLIDE ACETATE PA,SP LEUPROLIDE 2WK 14 MG/2.8 ML KT LEUPROLIDE ACETATE PA,SP LYSODREN 500 MG TABLET LYSODREN PA,SP Prior Authorization Required NILUTAMIDE 150 MG TABLET NILUTAMIDE PA,SP Prior Authorization Required XTANDI 40 MG CAPSULE XTANDI PA,,SP ZYTIGA 250 MG TABLET ZYTIGA PA,,SP Antineoplastic - Immunomodulators INTRON A 10 MILLION UNITS VIAL INTRON A PA,SP Prior Authorization Required INTRON A 18 MILLION UNIT/3 ML INTRON A PA,SP Prior Authorization Required INTRON A 18 MILLION UNITS VIAL INTRON A PA,SP Prior Authorization Required INTRON A 25 MILLION UNIT/2.5 ML INTRON A PA,SP Prior Authorization Required INTRON A 50 MILLION UNITS VIAL INTRON A PA,SP Prior Authorization Required POMALYST 1 MG CAPSULE POMALYST PA,SP Prior Authorization Required POMALYST 2 MG CAPSULE POMALYST PA,SP Prior Authorization Required POMALYST 3 MG CAPSULE POMALYST PA,SP Prior Authorization Required POMALYST 4 MG CAPSULE POMALYST PA,SP Prior Authorization Required REVLIMID 10 MG CAPSULE REVLIMID PA,,SP REVLIMID 15 MG CAPSULE REVLIMID PA,,SP REVLIMID 2.5 MG CAPSULE REVLIMID PA,SP Prior Authorization Required REVLIMID 20 MG CAPSULE REVLIMID PA,SP Prior Authorization Required REVLIMID 25 MG CAPSULE REVLIMID PA,,SP REVLIMID 5 MG CAPSULE REVLIMID PA,,SP Antineoplastic - Retinoids and Retinoid Receptor Agonists TARGRETIN 75 MG CAPSULE TARGRETIN PA,SP Prior Authorization Required TRETINOIN 10 MG CAPSULE TRETINOIN PA Prior Authorization Required Antineoplastic - Systemic Enzyme Inhibitors AFINITOR 10 MG TABLET AFINITOR PA,,SP AFINITOR 2.5 MG TABLET AFINITOR PA,,SP AFINITOR 5 MG TABLET AFINITOR PA,,SP AFINITOR 7.5 MG TABLET AFINITOR PA,SP Prior Authorization Required AFINITOR DISPERZ 2 MG TABLET AFINITOR DISPERZ PA,,SP AFINITOR DISPERZ 3 MG TABLET AFINITOR DISPERZ PA,,SP AFINITOR DISPERZ 5 MG TABLET AFINITOR DISPERZ PA,,SP 13

14 Prior Authorization Information Antineoplastic - Systemic Enzyme Inhibitors FARYDAK 10 MG CAPSULE FARYDAK PA,SP Prior Authorization Required FARYDAK 15 MG CAPSULE FARYDAK PA,SP Prior Authorization Required FARYDAK 20 MG CAPSULE FARYDAK PA,SP Prior Authorization Required IDHIFA 100 MG TABLET IDHIFA PA Prior Authorization Required IDHIFA 50 MG TABLET IDHIFA PA Prior Authorization Required JAKAFI 10 MG TABLET JAKAFI PA,,SP JAKAFI 15 MG TABLET JAKAFI PA,,SP JAKAFI 20 MG TABLET JAKAFI PA,,SP JAKAFI 25 MG TABLET JAKAFI PA,,SP JAKAFI 5 MG TABLET JAKAFI PA,,SP ZOLINZA 100 MG CAPSULE ZOLINZA PA,SP Prior Authorization Required Antineoplastic - Topoisomerase Inhibitors ETOPOSIDE 50 MG CAPSULE ETOPOSIDE PA,SP Prior Authorization Required HYCAMTIN 0.25 MG CAPSULE HYCAMTIN PA,SP Prior Authorization Required HYCAMTIN 1 MG CAPSULE HYCAMTIN PA,SP Prior Authorization Required Antiparasitics ATOVAQUONE 750 MG/5 ML SUSP ATOVAQUONE PA,SP Prior Authorization Required BENZNIDAZOLE 100 MG TABLET BENZNIDAZOLE PA Prior Authorization required BENZNIDAZOLE 12.5 MG TABLET BENZNIDAZOLE PA Prior Authorization required DARAPRIM 25 MG TABLET DARAPRIM PA,,SP MEFLOQUINE HCL 250 MG TABLET MEFLOQUINE HCL PA, Antivirals ADEFOVIR DIPIVOXIL 10 MG TAB ADEFOVIR DIPIVOXIL SP ENTECAVIR 0.5 MG TABLET ENTECAVIR SP ENTECAVIR 1 MG TABLET ENTECAVIR SP LAMIVUDINE 100 MG TABLET LAMIVUDINE SP LAMIVUDINE HBV 100 MG TABLET LAMIVUDINE HBV SP VALGANCICLOVIR 450 MG TABLET VALGANCICLOVIR HCL PA,,SP Prior Authorization Required VEMLIDY 25 MG TABLET VEMLIDY SP Calcium and Bone Metabolism Regulators FORTEO 600 MCG/2.4 ML PEN INJ FORTEO PA,,SP SENSIPAR 30 MG TABLET SENSIPAR PA,,SP SENSIPAR 60 MG TABLET SENSIPAR PA,,SP SENSIPAR 90 MG TABLET SENSIPAR PA,,SP TYMLOS 80 MCG DOSE PEN INJECTR TYMLOS PA,SP Chelating Agents CHEMET 100 MG CAPSULE CHEMET SP 14

15 Prior Authorization Information Chemotherapy Rescue-Antidote Agents LEUCOVORIN CALCIUM 10 MG TAB LEUCOVORIN CALCIUM SP LEUCOVORIN CALCIUM 15 MG TAB LEUCOVORIN CALCIUM SP LEUCOVORIN CALCIUM 25 MG TAB LEUCOVORIN CALCIUM SP LEUCOVORIN CALCIUM 5 MG TAB LEUCOVORIN CALCIUM SP MESNEX 400 MG TABLET MESNEX PA,SP Prior Authorization Required Contraceptives Oral LAYOLIS FE CHEWABLE TABLET LAYOLIS FE PA Restricted to Females Only WYMZYA FE CHEWABLE TABLET WYMZYA FE PA Restricted to Females Only ZENCHENT FE TABLET CHEWABLE ZENCHENT FE PA Restricted to Females Only Cystic Fibrosis Therapy Agents BETHKIS 300 MG/4 ML AMPULE BETHKIS PA,SP Prior Authorization Required CAYSTON 75 MG INHAL SOLUTION CAYSTON PA,SP Prior Authorization Required KITABIS PAK 300 MG/5 ML KITABIS PAK PA,SP Prior Authorization Required TOBI PODHALER 28 MG INHALE CAP TOBI PODHALER PA,SP Prior Authorization Required TOBRAMYCIN 300 MG/5 ML AMPULE TOBRAMYCIN PA,SP Prior Authorization Required Dermatological - Antineoplastic or Premalignant Lesions DICLOFENAC SODIUM 3% GEL DICLOFENAC SODIUM PA Prior Authorization Required FLUOROURACIL 0.5% CREAM FLUOROURACIL PA Prior Authorization Required FLUOROURACIL 5% CREAM FLUOROURACIL PA Prior Authorization Required Dermatological - Antipsoriatics ACITRETIN 10 MG CAPSULE ACITRETIN PA, Prior Authorization Required ACITRETIN 17.5 MG CAPSULE ACITRETIN PA, Prior Authorization Required ACITRETIN 25 MG CAPSULE ACITRETIN PA, Prior Authorization Required CALCIPOTRIENE 0.005% OINTMENT CALCIPOTRIENE PA, Prior Authorization Required CALCIPOTRIENE 0.005% SOLUTION CALCIPOTRIENE PA, Dermatological - Glucocorticoids and Combinations CLOBETASOL 0.05% CREAM CLOBETASOL PROPIONATE PA, Prior Authorization Required CLOBETASOL 0.05% OINTMENT CLOBETASOL PROPIONATE PA, Prior Authorization Required CLOBETASOL 0.05% SOLUTION CLOBETASOL PROPIONATE PA, Prior Authorization Required Dermatological - Immunomodulating Agents IMIQUIMOD 5% CREAM PACKET IMIQUIMOD PA, Prior Authorization Required Dermatological - Immunosuppressive Agents ELIDEL 1% CREAM ELIDEL PA, TACROLIMUS 0.03% OINTMENT TACROLIMUS PA, Prior Authorization Required TACROLIMUS 0.1% OINTMENT TACROLIMUS PA, Prior Authorization Required 15

16 Prior Authorization Information Diabetic Therapy ALOGLIPTIN 12.5 MG TABLET ALOGLIPTIN PA Prior Authorization Required ALOGLIPTIN 25 MG TABLET ALOGLIPTIN PA Prior Authorization Required ALOGLIPTIN 6.25 MG TABLET ALOGLIPTIN PA Prior Authorization Required ALOGLIPTIN-METFORMIN ALOGLIPTIN-METFORMIN PA Prior Authorization Required ALOGLIPTIN-METFORMIN ALOGLIPTIN-METFORMIN PA Prior Authorization Required ALOGLIPTIN-PIOGLIT MG ALOGLIPTIN-PIOGLITAZONE PA, Prior Authorization Required ALOGLIPTIN-PIOGLIT MG ALOGLIPTIN-PIOGLITAZONE PA, Prior Authorization Required ALOGLIPTIN-PIOGLIT MG ALOGLIPTIN-PIOGLITAZONE PA, Prior Authorization Required ALOGLIPTIN-PIOGLIT MG TB ALOGLIPTIN-PIOGLITAZONE PA, Prior Authorization Required ALOGLIPTIN-PIOGLIT MG TB ALOGLIPTIN-PIOGLITAZONE PA, Prior Authorization Required ALOGLIPTIN-PIOGLIT MG TB ALOGLIPTIN-PIOGLITAZONE PA, Prior Authorization Required HUMULIN R 500 UNITS/ML VIAL HUMULIN R U-500 PA Prior Authorization Required INVOKAMET 150-1,000 MG TABLET INVOKAMET PA, INVOKAMET MG TABLET INVOKAMET PA, INVOKAMET 50-1,000 MG TABLET INVOKAMET PA, INVOKAMET MG TABLET INVOKAMET PA, INVOKAMET XR 150-1,000 MG TAB INVOKAMET XR PA, Prior Authorization Required; Limit 60 tablets per 30 days INVOKAMET XR MG TABLET INVOKAMET XR PA, Prior Authorization Required; Limit 60 tablets per 30 days INVOKAMET XR 50-1,000 MG TAB INVOKAMET XR PA, Prior Authorization Required; Limit 60 tablets per 30 days INVOKAMET XR MG TABLET INVOKAMET XR PA, Prior Authorization Required; Limit 60 tablets per 30 days INVOKANA 100 MG TABLET INVOKANA PA, INVOKANA 300 MG TABLET INVOKANA PA, JANUMET 50-1,000 MG TABLET JANUMET PA, JANUMET MG TABLET JANUMET PA, JANUMET XR 100-1,000 MG TABLET JANUMET XR PA, JANUMET XR 50-1,000 MG TABLET JANUMET XR PA, JANUMET XR MG TABLET JANUMET XR PA, JANUVIA 100 MG TABLET JANUVIA PA, JANUVIA 25 MG TABLET JANUVIA PA, JANUVIA 50 MG TABLET JANUVIA PA, JARDIANCE 10 MG TABLET JARDIANCE PA, Prior Authorization required; limited to 1 tablet per day. JARDIANCE 25 MG TABLET JARDIANCE PA, Prior Authorization required; limited to 1 tablet per day. JENTADUETO 2.5 MG-1,000 MG TAB JENTADUETO PA, JENTADUETO 2.5 MG-500 MG TAB JENTADUETO PA, JENTADUETO 2.5 MG-850 MG TAB JENTADUETO PA, SYNJARDY ,000 MG TABLET SYNJARDY PA, Prior Authorization required; limit 2 tablets per day 16

17 Prior Authorization Information Diabetic Therapy SYNJARDY MG TABLET SYNJARDY PA, Prior Authorization required; limit 2 tablets per day SYNJARDY 5-1,000 MG TABLET SYNJARDY PA, Prior Authorization required; limit 2 tablets per day SYNJARDY MG TABLET SYNJARDY PA, Prior Authorization required; limit 2 tablets per day SYNJARDY XR 10-1,000 MG TABLET SYNJARDY XR PA, Prior Authorization required; limit 1 tablet per day SYNJARDY XR ,000 MG TAB SYNJARDY XR PA, Prior Authorization required; limit 2 tablets per day SYNJARDY XR 25-1,000 MG TABLET SYNJARDY XR PA, Prior Authorization required; limit 1 tablet per day SYNJARDY XR 5-1,000 MG TABLET SYNJARDY XR PA, Prior Authorization required; limit 2 tablets per day TANZEUM 30 MG PEN INJECT TANZEUM PA, TANZEUM 50 MG PEN INJECT TANZEUM PA, TRADJENTA 5 MG TABLET TRADJENTA PA, VICTOZA 2-PAK 18 MG/3 ML PEN VICTOZA 2-PAK PA, VICTOZA 3-PAK 18 MG/3 ML PEN VICTOZA 3-PAK PA, Prior Authorization Required Hematopoietic Agents ARANESP 10 MCG/0.4 ML SYRINGE ARANESP PA,SP Prior Authorization Required ARANESP 100 MCG/0.5 ML SYRINGE ARANESP PA,SP Prior Authorization Required ARANESP 100 MCG/ML VIAL ARANESP PA,SP Prior Authorization Required ARANESP 150 MCG/0.3 ML SYRINGE ARANESP PA,SP Prior Authorization Required ARANESP 150 MCG/0.75 ML VIAL ARANESP PA,SP Prior Authorization Required ARANESP 200 MCG/0.4 ML SYRINGE ARANESP PA,SP Prior Authorization Required ARANESP 200 MCG/ML VIAL ARANESP PA,SP Prior Authorization Required ARANESP 25 MCG/0.42 ML SYRING ARANESP PA,SP Prior Authorization Required ARANESP 25 MCG/ML VIAL ARANESP PA,SP Prior Authorization Required ARANESP 300 MCG/0.6 ML SYRINGE ARANESP PA,SP Prior Authorization Required ARANESP 300 MCG/ML VIAL ARANESP PA,SP Prior Authorization Required ARANESP 40 MCG/0.4 ML SYRINGE ARANESP PA,SP Prior Authorization Required ARANESP 40 MCG/ML VIAL ARANESP PA,SP Prior Authorization Required ARANESP 500 MCG/1 ML SYRINGE ARANESP PA,SP Prior Authorization Required ARANESP 60 MCG/0.3 ML SYRINGE ARANESP PA,SP Prior Authorization Required ARANESP 60 MCG/ML VIAL ARANESP PA,SP Prior Authorization Required EPOGEN 10,000 UNITS/ML VIAL EPOGEN PA,SP Prior Authorization Required EPOGEN 2,000 UNITS/ML VIAL EPOGEN PA,SP Prior Authorization Required EPOGEN 20,000 UNITS/2 ML VIAL EPOGEN PA,SP Prior Authorization Required EPOGEN 20,000 UNITS/ML VIAL EPOGEN PA,SP Prior Authorization Required EPOGEN 3,000 UNITS/ML VIAL EPOGEN PA,SP Prior Authorization Required EPOGEN 4,000 UNITS/ML VIAL EPOGEN PA,SP Prior Authorization Required GRANIX 300 MCG/0.5 ML SAFE SYR GRANIX PA,SP Prior Authorization Required 17

18 Prior Authorization Information Hematopoietic Agents GRANIX 300 MCG/0.5 ML SYRINGE GRANIX PA,SP Prior Authorization Required GRANIX 480 MCG/0.8 ML SAFE SYR GRANIX PA,SP Prior Authorization Required GRANIX 480 MCG/0.8 ML SYRINGE GRANIX PA,SP Prior Authorization Required NEUPOGEN 300 MCG/0.5 ML SYR NEUPOGEN PA,SP Prior Authorization Required NEUPOGEN 300 MCG/ML VIAL NEUPOGEN PA,SP Prior Authorization Required NEUPOGEN 480 MCG/0.8 ML SYR NEUPOGEN PA,SP Prior Authorization Required NEUPOGEN 480 MCG/1.6 ML VIAL NEUPOGEN PA,SP Prior Authorization Required PROCRIT 10,000 UNITS/ML VIAL PROCRIT PA,SP Prior Authorization Required PROCRIT 2,000 UNITS/ML VIAL PROCRIT PA,SP Prior Authorization Required PROCRIT 20,000 UNITS/ML VIAL PROCRIT PA,SP Prior Authorization Required PROCRIT 3,000 UNITS/ML VIAL PROCRIT PA,SP Prior Authorization Required PROCRIT 4,000 UNITS/ML VIAL PROCRIT PA,SP Prior Authorization Required PROCRIT 40,000 UNITS/ML VIAL PROCRIT PA,SP Prior Authorization Required Hepatic Hormones (Hormones Secreted by the Liver) INCRELEX 40 MG/4 ML VIAL INCRELEX PA,SP Prior Authorization Required Hyperuricemia Therapy ULORIC 40 MG TABLET ULORIC PA, ULORIC 80 MG TABLET ULORIC PA, Immunosuppressive - Inosine Monophosphate Dehydrogenase Inhibitors MYCOPHENOLATE 200 MG/ML SUSP MYCOPHENOLATE MOFETIL SP Immunosuppressive - Mammalian Target of Rapamycin (mtor) Inhibitors SIROLIMUS 0.5 MG TABLET SIROLIMUS SP SIROLIMUS 1 MG TABLET SIROLIMUS SP SIROLIMUS 2 MG TABLET SIROLIMUS SP Inflammatory Bowel Agents HUMIRA 20 MG/0.4 ML SYRINGE HUMIRA PA,,SP HUMIRA 40 MG/0.8 ML PEN HUMIRA PEN PA,,SP HUMIRA 40 MG/0.8 ML SYRINGE HUMIRA PA,,SP HUMIRA PED CROHNS 40 MG/0.8 ML HUMIRA PEDIATRIC CROHN S PA,,SP Prior Authorization Required HUMIRA PEN CROHN-UC-HS STARTER HUMIRA PEN PSORIASIS-UVEITIS STARTER HUMIRA PEN CROHN-UC-HS STARTER HUMIRA PEN PSORIASIS- UVEITIS Interstitial Cystitis Agents PA,,SP PA,,SP Prior Authorization Required Prior Authorization Required; Limited to 4 pens per 28 days ELMIRON 100 MG CAPSULE ELMIRON PA, 18

19 Prior Authorization Information Migraine Therapy SUMATRIPTAN 20 MG NASAL SPRAY SUMATRIPTAN PA, Prior Authorization required; Limited to 1 fill of 1 unit per 30 days SUMATRIPTAN 4 MG/0.5 ML CART SUMATRIPTAN SUCCINATE PA, Prior Authorization Required SUMATRIPTAN 4 MG/0.5 ML INJECT SUMATRIPTAN SUCCINATE PA, Prior Authorization Required SUMATRIPTAN 5 MG NASAL SPRAY SUMATRIPTAN PA, Prior Authorization required; Limited to 1 fill of 1 unit per 30 days SUMATRIPTAN 6 MG/0.5 ML INJECT SUMATRIPTAN SUCCINATE PA, Prior Authorization Required SUMATRIPTAN 6 MG/0.5 ML REFILL SUMATRIPTAN SUCCINATE PA, Prior Authorization Required SUMATRIPTAN 6 MG/0.5 ML VIAL SUMATRIPTAN SUCCINATE PA, Prior Authorization Required Mucolytics PULMOZYME 1 MG/ML AMPUL PULMOZYME PA,,SP Multiple Sclerosis Agent - Interferons AVONEX 30 MCG VIAL KIT AVONEX PA,,SP Prior Authorization Required AVONEX PEN 30 MCG/0.5 ML KIT AVONEX PEN PA,,SP AVONEX PREFILLED SYR 30 MCG KIT AVONEX PA,,SP Multiple Sclerosis Agent - Others GLATIRAMER 20 MG/ML SYRINGE GLATIRAMER ACETATE PA,,SP GLATIRAMER 40 MG/ML SYRINGE GLATIRAMER ACETATE PA,,SP Prior Authorization required; limit 12 syringes per 28 days GLATOPA 20 MG/ML SYRINGE GLATOPA PA,,SP Prior Authorization Required TECFIDERA DR 120 MG CAPSULE TECFIDERA PA,,SP TECFIDERA DR 240 MG CAPSULE TECFIDERA PA,,SP TECFIDERA STARTER PACK TECFIDERA PA,,SP Multiple Sclerosis Agent - Potassium Channel Blocker AMPYRA ER 10 MG TABLET AMPYRA PA,SP Prior Authorization Required Multiple Sclerosis Agent - Sphingosine 1-phosphate receptor modulator GILENYA 0.5 MG CAPSULE GILENYA PA,,SP Passive Immunizing Agents SYNAGIS 100 MG/1 ML VIAL SYNAGIS PA,SP Prior Authorization Required SYNAGIS 50 MG/0.5 ML VIAL SYNAGIS PA,SP Prior Authorization Required Phosphate Binders FOSRENOL 1,000 MG TABLET CHEW FOSRENOL PA Prior Authorization Required FOSRENOL 500 MG TABLET CHEW FOSRENOL PA Prior Authorization Required FOSRENOL 750 MG TABLET CHEW FOSRENOL PA Prior Authorization Required LANTHANUM CARB 1,000 MG TB CHW LANTHANUM CARBONATE PA Prior Authorization required;must meet Pharmacy Approval Criteria 19

20 Prior Authorization Information Phosphate Binders LANTHANUM CARB 500 MG TAB CHEW LANTHANUM CARB 750 MG TAB CHEW LANTHANUM CARBONATE PA Prior Authorization required;must meet Pharmacy Approval Criteria LANTHANUM CARBONATE PA Prior Authorization required;must meet Pharmacy Approval Criteria RENAGEL 400 MG TABLET RENAGEL PA Prior Authorization Required RENAGEL 800 MG TABLET RENAGEL PA Prior Authorization Required RENVELA 800 MG TABLET RENVELA PA Prior Authorization Required SEVELAMER CARBONATE 800 MG TAB SEVELAMER CARBONATE PA Prior Authorization required;must meet Pharmacy Approval Criteria Platelet Aggregation Inhibitors and Combinations ANAGRELIDE HCL 0.5 MG CAPSULE ANAGRELIDE HCL SP ANAGRELIDE HCL 1 MG CAPSULE ANAGRELIDE HCL SP Posterior Pituitary Hormones DESMOPRESSIN 0.01% SOLUTION DESMOPRESSIN ACETATE PA Prior Authorization Required DESMOPRESSIN 0.01% SPRAY DESMOPRESSIN ACETATE PA Prior Authorization Required DESMOPRESSIN 10 MCG/0.1 ML SPR DESMOPRESSIN ACETATE PA Prior Authorization Required STIMATE 1.5 MG/ML NASAL SPRAY STIMATE PA,SP Prior Authorization Required Sickle Cell Anemia Agents ENDARI 5 GRAM POWDER PACKET ENDARI PA Prior Authorization required 20

21 2018 Harbor Health Plan Medicaid Formulary ZARXIO 300 MCG/0.5 ML SYRINGE ZARXIO PA,SP Prior Authorization Required ZARXIO 480 MCG/0.8 ML SYRINGE ZARXIO PA,SP Prior Authorization Required Acne Therapy BENZOYL PEROXIDE 10% GEL BENZOYL PEROXIDE CLARAVIS 10 MG CAPSULE CLARAVIS PA, Prior Authorization Required CLARAVIS 20 MG CAPSULE CLARAVIS PA, Prior Authorization Required CLARAVIS 30 MG CAPSULE CLARAVIS PA, Prior Authorization Required CLARAVIS 40 MG CAPSULE CLARAVIS PA, Prior Authorization Required CLINDAMYCIN PH 1% SOLUTION CLINDAMYCIN PHOS 1% PLEDGET CLINDAMYCIN-BENZOYL PEROX 1-5% CLINDAMYCIN PHOSPHATE CLINDAMYCIN PHOSPHATE CLINDAMYCIN-BENZOYL PEROXIDE DIFFERIN 0.1% GEL DIFFERIN ERYTHROMYCIN 2% SOLUTION METRONIDAZOLE 0.75% CREAM SOD SULFACET-SULFUR 10-5% CLSR SODIUM SULF-SULFUR CLEANSER ERYTHROMYCIN METRONIDAZOLE SODIUM SULFACETAMIDE- SULFUR SODIUM SULFACETAMIDE- SULFUR Analgesic, Anti-inflammatory or Antipyretic - Non-Narcotic BUTALB-ACETAMINOPHEN-CAFF TAB BUTALBIT-ACETAMINOPHEN-CAFF CP BUTALBITAL-ACETAMINOPHEN MG TAB BUTALBITAL-ASA-CAFFEINE CAP BUTALBITAL-ACETAMINOPHEN- CAFFE BUTALBITAL-ACETAMINOPHEN- CAFFE BUTALBITAL-ACETAMINOPHEN BUTALBITAL-ASPIRIN- CAFFEINE CAPACET CAPSULE CAPACET CELECOXIB 100 MG CAPSULE CELECOXIB Prior Authorization Required CELECOXIB 200 MG CAPSULE CELECOXIB Prior Authorization Required CELECOXIB 400 MG CAPSULE CELECOXIB Prior Authorization Required CELECOXIB 50 MG CAPSULE CELECOXIB Prior Authorization Required CHOLINE MAG TRISAL LIQUID DICLOFENAC SOD DR 25 MG TAB DICLOFENAC SOD DR 50 MG TAB DICLOFENAC SOD DR 75 MG TAB DICLOFENAC SOD EC 25 MG TAB DICLOFENAC SOD EC 50 MG TAB DICLOFENAC SOD EC 75 MG TAB DICLOFENAC SOD ER 100 MG TAB CHOLINE MAG TRISALICYLATE DICLOFENAC SODIUM DICLOFENAC SODIUM DICLOFENAC SODIUM DICLOFENAC SODIUM DICLOFENAC SODIUM DICLOFENAC SODIUM DICLOFENAC SODIUM ER ENBREL 25 MG KIT ENBREL PA,,SP ENBREL 25 MG/0.5 ML SYRINGE ENBREL PA,,SP 21

22 2018 Harbor Health Plan Medicaid Formulary Analgesic, Anti-inflammatory or Antipyretic - Non-Narcotic ENBREL 50 MG/ML SURECLICK SYR ENBREL SURECLICK PA, ENBREL 50 MG/ML SYRINGE ENBREL PA,,SP ESGIC MG TABLET ESGIC ESGIC CAPSULE ESGIC ETODOLAC 200 MG CAPSULE ETODOLAC ETODOLAC 300 MG CAPSULE ETODOLAC ETODOLAC 400 MG TABLET ETODOLAC ETODOLAC 500 MG TABLET ETODOLAC FENOPROFEN 600 MG TABLET FLURBIPROFEN 100 MG TABLET FLURBIPROFEN 50 MG TABLET FENOPROFEN CALCIUM FLURBIPROFEN FLURBIPROFEN HUMIRA 10 MG/0.2 ML SYRINGE HUMIRA PA,,SP IBU 400 MG TABLET IBU 600 MG TABLET IBU 800 MG TABLET IBUPROFEN 100 MG/5 ML SUSP IBUPROFEN IBUPROFEN 400 MG TABLET IBUPROFEN 600 MG TABLET IBUPROFEN 800 MG TABLET INDOMETHACIN 25 MG CAPSULE INDOMETHACIN 50 MG CAPSULE INDOMETHACIN ER 75 MG CAPSULE KETOROLAC 10 MG TABLET IBU IBU IBU IBUPROFEN IBUPROFEN IBUPROFEN INDOMETHACIN INDOMETHACIN INDOMETHACIN ER KETOROLAC TROMETHAMINE LEFLUNOMIDE 10 MG TABLET LEFLUNOMIDE LEFLUNOMIDE 20 MG TABLET LEFLUNOMIDE MARTEN-TAB TABLET MARTEN-TAB MELOXICAM 15 MG TABLET MELOXICAM MELOXICAM 7.5 MG TABLET MELOXICAM METHOTREXATE 2.5 MG TABLET METHOTREXATE NABUMETONE 500 MG TABLET NABUMETONE NABUMETONE 750 MG TABLET NABUMETONE NAPROXEN 125 MG/5 ML SUSPEN NAPROXEN Limited to members age 12 and younger; Prior Authorization Required NAPROXEN 250 MG TABLET NAPROXEN 375 MG TABLET NAPROXEN 500 MG KIT NAPROXEN 500 MG TABLET NAPROXEN DR 375 MG TABLET NAPROXEN DR 500 MG TABLET NAPROXEN EC 375 MG TABLET NAPROXEN EC 500 MG TABLET NAPROXEN NAPROXEN NAPROXEN NAPROXEN NAPROXEN NAPROXEN NAPROXEN NAPROXEN OTEZLA 28 DAY STARTER PACK OTEZLA PA,SP Prior Authorization Required 22

23 2018 Harbor Health Plan Medicaid Formulary Analgesic, Anti-inflammatory or Antipyretic - Non-Narcotic OTEZLA 30 MG TABLET OTEZLA PA,SP Prior Authorization Required OTEZLA STARTER PACK OTEZLA PA,SP Prior Authorization Required PIROXICAM 10 MG CAPSULE PIROXICAM PIROXICAM 20 MG CAPSULE PIROXICAM SULINDAC 150 MG TABLET SULINDAC 200 MG TABLET SULINDAC SULINDAC TENCON MG TABLET TENCON XATMEP 2.5 MG/ML ORAL SOLUTION XATMEP PA Prior Authorization Required ZEBUTAL MG CAPSULE ZEBUTAL Analgesics - Narcotic ACETAMINOPHEN-COD #2 TABLET ACETAMINOPHEN-CODEINE ACETAMINOPHEN-COD #3 TABLET ACETAMINOPHEN-CODEINE ACETAMINOPHEN-COD #4 TABLET ACETAMINOPHEN-CODEINE ACETAMINOPHEN-CODEINE 120 MG- 12 MG/5 ML SOLUTION ACETAMINOPHEN-CODEINE MG/5 ML BUTALBITAL COMP-CODEINE #3 CAP BUTALBITAL-CAFF-ACETAMINOPHEN- COD CAP ACETAMINOPHEN-CODEINE ACETAMINOPHEN-CODEINE BUTALBITAL COMPOUND- CODEINE BUTALB-CAFF-ACETAMINOPH- CODEIN CODEINE SULFATE 15 MG TABLET CODEINE SULFATE CODEINE SULFATE 30 MG TABLET CODEINE SULFATE CODEINE SULFATE 60 MG TABLET CODEINE SULFATE FENTANYL 100 MCG/HR PATCH FENTANYL PA, Prior Authorization Required FENTANYL 12 MCG/HR PATCH FENTANYL PA, Prior Authorization Required FENTANYL 25 MCG/HR PATCH FENTANYL PA, Prior Authorization Required FENTANYL 50 MCG/HR PATCH FENTANYL PA, Prior Authorization Required FENTANYL 75 MCG/HR PATCH FENTANYL PA, Prior Authorization Required HYDROCODONE-ACETAMINOPHEN MG TABLET HYDROCODONE-ACETAMINOPHEN MG TABLET HYDROCODONE-ACETAMINOPHEN MG TABLET HYDROCODONE-ACETAMINOPHEN MG/15 ML SOLUTION HYDROMORPHONE 1 MG/ML SOLUTION HYDROCODONE- ACETAMINOPHEN HYDROCODONE- ACETAMINOPHEN HYDROCODONE- ACETAMINOPHEN HYDROCODONE- ACETAMINOPHEN HYDROMORPHONE HCL HYDROMORPHONE 2 MG TABLET HYDROMORPHONE HCL HYDROMORPHONE 3 MG SUPPOS HYDROMORPHONE HCL HYDROMORPHONE 4 MG TABLET HYDROMORPHONE HCL HYDROMORPHONE 5 MG/5 ML SOLN HYDROMORPHONE HCL MEPERIDINE 100 MG TABLET MEPERIDINE HCL 23

24 2018 Harbor Health Plan Medicaid Formulary Analgesics - Narcotic MEPERIDINE 50 MG TABLET MEPERIDINE HCL MEPERIDINE 50 MG/5 ML SOLUTION MEPERIDINE HCL METHADONE 10 MG/5 ML SOLUTION METHADONE HCL METHADONE 10 MG/ML ORAL CONC METHADONE HCL METHADONE 5 MG/5 ML SOLUTION METHADONE HCL METHADONE HCL 10 MG TABLET METHADONE HCL METHADONE HCL 5 MG TABLET METHADONE HCL MORPHINE SULF 10 MG/5 ML SOLN MORPHINE SULFATE MORPHINE SULF 100 MG/5 ML (20 MG/ ML) SOLUTION MORPHINE SULFATE MORPHINE SULF 100 MG/5 ML SOLN MORPHINE SULFATE MORPHINE SULF 20 MG/5 ML SOLN MORPHINE SULFATE MORPHINE SULF ER 100 MG TABLET MORPHINE SULFATE ER MORPHINE SULF ER 15 MG TABLET MORPHINE SULFATE ER MORPHINE SULF ER 200 MG TABLET MORPHINE SULFATE ER MORPHINE SULF ER 30 MG TABLET MORPHINE SULFATE ER MORPHINE SULF ER 60 MG TABLET MORPHINE SULFATE ER MORPHINE SULFATE IR 15 MG TAB MORPHINE SULFATE MORPHINE SULFATE IR 30 MG TAB MORPHINE SULFATE OXYCODONE HCL 5 MG TABLET OXYCODONE HCL OXYCODONE HCL 5 MG/5 ML SOLN OXYCODONE HCL OXYCODONE-ACETAMINOPHEN MG TAB OXYCODONE-ACETAMINOPHEN MG TABLET OXYCODONE-ACETAMINOPHEN MG TAB OXYCODONE-ACETAMINOPHEN MG TABLET OXYCODONE-ACETAMINOPHEN MG TABLET OXYCODONE- ACETAMINOPHEN OXYCODONE- ACETAMINOPHEN OXYCODONE- ACETAMINOPHEN OXYCODONE- ACETAMINOPHEN OXYCODONE- ACETAMINOPHEN PENTAZOCINE-NALOXONE TABLET PENTAZOCINE-NALOXONE HCL TRAMADOL HCL 50 MG TABLET TRAMADOL HCL Androgen-Anabolic TESTOSTERON CYP 1,000 MG/10 ML TESTOSTERON CYP 2,000 MG/10 ML TESTOSTERONE CYP 100 MG/ML TESTOSTERONE CYP 200 MG/ML TESTOSTERONE CYPIONATE TESTOSTERONE CYPIONATE TESTOSTERONE CYPIONATE TESTOSTERONE CYPIONATE Angina Therapy ISOSORBIDE DINITR ER 40 MG TAB ISOSORBIDE DINITRATE 10 MG TAB ISOSORBIDE DINITRATE 20 MG TAB ISOSORBIDE DINITRATE 30 MG TAB ISOSORBIDE DINITRATE ER ISOSORBIDE DINITRATE ISOSORBIDE DINITRATE ISOSORBIDE DINITRATE 24

25 2018 Harbor Health Plan Medicaid Formulary Angina Therapy ISOSORBIDE DINITRATE 5 MG TAB ISOSORBIDE MONONIT 10 MG TAB ISOSORBIDE MONONIT 20 MG TAB ISOSORBIDE MONONIT ER 120 MG ISOSORBIDE MONONIT ER 30 MG TB ISOSORBIDE MONONIT ER 60 MG TB NITRO-BID 2% OINTMENT ISOSORBIDE DINITRATE ISOSORBIDE MONONITRATE ISOSORBIDE MONONITRATE ISOSORBIDE MONONITRATE ER ISOSORBIDE MONONITRATE ER ISOSORBIDE MONONITRATE ER NITRO-BID NITROGLYCERIN 0.1 MG/HR PATCH NITROGLYCERIN PATCH NITROGLYCERIN 0.2 MG/HR PATCH NITROGLYCERIN PATCH NITROGLYCERIN 0.3 MG TABLET SL NITROGLYCERIN 0.4 MG TABLET SL NITROGLYCERIN NITROGLYCERIN NITROGLYCERIN 0.4 MG/HR PATCH NITROGLYCERIN PATCH NITROGLYCERIN 0.6 MG TABLET SL NITROGLYCERIN NITROGLYCERIN 0.6 MG/HR PATCH NITROGLYCERIN PATCH NITROGLYCERIN ER 2.5 MG CAP NITROGLYCERIN ER 6.5 MG CAP NITROGLYCERIN ER 9 MG CAPSULE NITROGLYCERIN NITROGLYCERIN NITROGLYCERIN NITROGLYCERIN LINGUAL 0.4 MG NITROGLYCERIN ST Requires trial and failure of Nitroglycerin sublingual tablets;must show trial and failure of Nitroglycerin tablets NITROSTAT 0.3 MG TABLET SL NITROSTAT 0.4 MG TABLET SL NITROSTAT 0.6 MG TABLET SL NITROSTAT NITROSTAT NITROSTAT RANEXA ER 1,000 MG TABLET RANEXA PA Prior Authorization Required RANEXA ER 500 MG TABLET RANEXA PA Prior Authorization Required Anorectal - Glucocorticoids HYDROCORTISONE 1% CREAM HYDROCORTISONE 2.5% CREAM HYDROCORTISONE HYDROCORTISONE Anterior Pituitary Hormones and Hormone Antagonists DANAZOL 100 MG CAPSULE DANAZOL 200 MG CAPSULE DANAZOL 50 MG CAPSULE DANAZOL DANAZOL DANAZOL NORDITROPIN FLEXPRO 10 MG/1.5 NORDITROPIN FLEXPRO PA,SP Prior Authorization Required NORDITROPIN FLEXPRO 15 MG/1.5 NORDITROPIN FLEXPRO PA,SP Prior Authorization Required NORDITROPIN FLEXPRO 30 MG/3 ML NORDITROPIN FLEXPRO PA,SP Prior Authorization Required NORDITROPIN FLEXPRO 5 MG/1.5 NORDITROPIN FLEXPRO PA,SP Prior Authorization Required OCTREOTIDE 1,000 MCG/ML VIAL OCTREOTIDE ACETATE PA,SP Prior Authorization Required OCTREOTIDE ACET 100 MCG/ML VL OCTREOTIDE ACETATE PA,SP Prior Authorization Required 25

Neighborhood Medicaid Formulary Changes: June 2017

Neighborhood Medicaid Formulary Changes: June 2017 Neighborhood Medicaid Formulary Changes: June 2017 The following changes to the Neighborhood Medicaid Formulary were recently approved by the Pharmacy and Therapeutics (P&T) Committee. All changes were

More information

AETNA BETTER HEALTH January 2017 Formulary Change(s)

AETNA BETTER HEALTH January 2017 Formulary Change(s) AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on March 1, 2017 Drug Name, Strength, Dosage Form ALFUZOSIN HCL ER 10

More information

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria Medications that require Step Therapy (ST) require trial and failure of preferred formulary agents prior to their authorization. If the prerequisite medications have been filled within the specified time

More information

Trusted Health Plan Formulary

Trusted Health Plan Formulary 2018 Trusted Health Plan Formulary Version 19; Effective 10/22/18 Introduction... 6 The Trusted Health Plan Pharmacy and Therapeutics Committee (P&T)... 6 Notice...6 Preface...6 Product Selection Criteria...

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider update Quarterly pharmacy formulary change notice Summary: The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018, Pharmacy and Therapeutics Committee

More information

STEP THERAPY CRITERIA

STEP THERAPY CRITERIA STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered under your medical or prescription

More information

AETNA BETTER HEALTH January 2017 Formulary Change(s)

AETNA BETTER HEALTH January 2017 Formulary Change(s) AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on February 1, 2017 Drug Name, Strength, Dosage Form IVERMECTIN 3 MG TABLET

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice Provider update Summary: Effective August 1, 2018, the preferred formulary changes detailed in the table below will apply to District of Columbia Healthy Families

More information

STEP THERAPY CRITERIA

STEP THERAPY CRITERIA STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered under your medical or prescription

More information

Aetna Better Health of Illinois Medicaid Formulary Updates

Aetna Better Health of Illinois Medicaid Formulary Updates October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice Provider update Summary: The formulary changes listed in the table below were reviewed and approved at our second quarter 2018, Pharmacy and Therapeutics Committee

More information

Trusted Health Plan Formulary

Trusted Health Plan Formulary 2018 Trusted Health Plan Formulary Effective 7/1/2018 Introduction... 6 The Trusted Health Plan Pharmacy and Therapeutics Committee (P&T)... 6 Notice...6 Preface...6 Product Selection Criteria... 6 Formulary

More information

The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016.

The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016. Q4 MHS PDL Changes Provider Notice The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016. Table 1: Summary of Medicaid PDL Additions

More information

Quarterly pharmacy formulary change

Quarterly pharmacy formulary change Medi-Cal Managed Care L. A. Care Major Risk Medical Insurance Program Provider Bulletin The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018 Pharmacy and

More information

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at our second quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice MEDICAID PROVIDER BULLETIN October 2018 The formulary changes listed in the table below were reviewed and approved at the second-quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider Bulletin October 2018 Quarterly pharmacy formulary change notice The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. The changes listed in the table

More information

Drug Formulary. A healthier you. A healthier community.

Drug Formulary. A healthier you. A healthier community. Drug Formulary This Formulary is up to date through its date of publication, November 2, 2016. Please contact NextLevel Health at 1.844.807.9734 or info@nlhpartners.com with any mistakes in the formulary.

More information

HEALTH SHARE/PROVIDENCE (OHP)

HEALTH SHARE/PROVIDENCE (OHP) HEALTH SHARE/PROVIDENCE (OHP) STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered

More information

Drug Name Tier Drug Name Tier

Drug Name Tier Drug Name Tier Drug Name Tier Drug Name Tier ABELCET 100 MG/20 ML VIAL 4 ACETYLCYSTEINE 10% VIAL 2 ACETYLCYSTEINE 20% VIAL 2 ACYCLOVIR 1,000 MG/20 ML VIAL 2 ACYCLOVIR 500 MG/10 ML VIAL 2 ADRUCIL 500 MG/10 ML VIAL 2 ALBUTEROL

More information

Alprazolam 0.25mg, 0.5mg, 1mg tablets

Alprazolam 0.25mg, 0.5mg, 1mg tablets Presbyterian Senior Care (HMO) / Presbyterian MediCare PPO Quantity Limits Effective November 1, 2014 For the most recent list of drugs or other questions, please contact the Presbyterian Customer Service

More information

UPDATE Ohana QUEST Integration Medicaid

UPDATE Ohana QUEST Integration Medicaid UPDATE Ohana QUEST Integration Medicaid Preferred Drug List June 29, 2015 Dear Provider: At the June 04, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes

More information

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs) Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 morphine sulfate 30 mg tablet er Opioid Analgesics, Short-acting fentanyl citrate 200 mcg lozenge hd hydrocodone/acetaminophen 5

More information

Step Therapy Approval Criteria

Step Therapy Approval Criteria Effective Date: 01/01/2018 This document contains Step Therapy Approval Criteria for the following medications: 1. Colcrys (colchicine) 2. Dovonex (calcipotriene) 3. Enbrel (etanercept) 4. Humira (adalimumab)

More information

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum This is a listing of the changes that have occurred in our formulary. Please carefully review these changes and call WellCare if you

More information

ALLERGIC RHINITIS-NASAL

ALLERGIC RHINITIS-NASAL ALLERGIC RHINITIS-NASAL FLUNISOLIDE Patient needs to have paid claims for any one of the following Step 1 drugs: NasaCort OTC, fluticasone Rx, fluticasone OTC, Budesonide OTC. Prior to filling the Step

More information

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria ALBENDAZOLE Mercy Care ALBENZA TABLET 200 MG ORAL Refer to PA Guideline for approval criteria 1 BRIMONIDINE-TIMOLOL COMBIGAN SOLUTION 0.2-0.5 % OPHTHALMIC Requires use of separate ingredients for at least

More information

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs

More information

Step Therapy Approval Criteria

Step Therapy Approval Criteria Effective Date: 01/01/2019 This document contains for the following medications: 1. Colcrys (colchicine) 2. Dovonex (calcipotriene) 3. Enbrel (etanercept) 4. Humira (adalimumab) 5. Imitrex Injection vial

More information

CMI Marketplace 2015 (List of Covered Drugs)

CMI Marketplace 2015 (List of Covered Drugs) Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 fentanyl citrate 200 mcg lozenge hd morphine sulfate 30 mg tablet er oxymorphone hcl 7.5 mg tab er 12h Opioid Analgesics, Short-acting

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider Bulletin April 2018 This table is used by HealthKeepers, Inc. to indicate formulary changes applicable to all Anthem HealthKeepers Plus members. These changes were reviewed and approved at the

More information

Your prescription benefit updates Formulary Updates - Effective January 1, 2019

Your prescription benefit updates Formulary Updates - Effective January 1, 2019 Your prescription benefit updates Formulary Updates - Effective January 1, 2019 Medications are grouped by the conditions they treat. Each medication is placed in a tier that shows the amount you will

More information

Aetna Better Health of Michigan 1333 Gratiot Avenue, Suite 400 Detroit, MI AETNA BETTER HEALTH January 2017 Formulary Change(s)

Aetna Better Health of Michigan 1333 Gratiot Avenue, Suite 400 Detroit, MI AETNA BETTER HEALTH January 2017 Formulary Change(s) AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on July 1, 2017 ADAPALENE 0.1% CREAM ADAPALENE 0.1% GEL ATORVASTATIN 10

More information

UPDATE WellCare s South Carolina

UPDATE WellCare s South Carolina September 3, 2015 UPDATE WellCare s South Carolina Preferred Drug List Dear Provider: At the September 3, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes

More information

Pharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017

Pharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017 Pharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017 DRUG LIST CHANGES Based on the availability of new prescription medications and Prime s National Pharmacy and Therapeutics Committee

More information

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS ANTIDIABETIC AGENTS - MISCELLANEOUS Glyxambi 10 mg-5 mg tablet Glyxambi 25 mg-5 mg tablet Invokamet 150 mg-1,000 mg tablet Invokamet 150 mg-500 mg tablet Invokamet 50 mg-1,000 mg tablet Invokamet 50 mg-500

More information

APREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE

APREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE APREPITANT Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil Oral Tablet 150, 200, 250, 50

More information

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018 ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG ORAL FETZIMA

More information

Step Therapy Requirements. Effective: 11/01/2018

Step Therapy Requirements. Effective: 11/01/2018 Effective: 11/01/2018 Updated 10/2018 ANTIDEPRESSANTS Sharp Health Plan (HMO) TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK

More information

Step Therapy Requirements. Effective: 05/01/2018

Step Therapy Requirements. Effective: 05/01/2018 Step Therapy Requirements Effective: 05/01/2018 ANTIDEPRESSANTS TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK VIIBRYD 10 MG

More information

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria ANTIDEPRESSANTS Trintellix 10 mg tablet Trintellix 20 mg tablet Trintellix 5 mg tablet Viibryd 10 mg (7)-20 mg (23) tablets in a dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet

More information

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017 Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017 Providers may call the Pharmacy Help Desk at 800-641-8921 for more information or questions about criteria. The formulary may change

More information

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs

More information

2017 Formulary Changes Year to Date

2017 Formulary Changes Year to Date 2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or

More information

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS ANTIDIABETIC AGENTS - MISCELLANEOUS GLYXAMBI 10 MG-5 MG GLYXAMBI 25 MG-5 MG INVOKAMET 150 MG-1,000 MG INVOKAMET 150 MG-500 MG INVOKAMET 50 MG-1,000 MG INVOKAMET 50 MG-500 MG INVOKAMET XR 150 MG-1,000 MG,

More information

TN Cover Rx Tennessee CoverRx MAC Price Change List As of: 04/26/2018

TN Cover Rx Tennessee CoverRx MAC Price Change List As of: 04/26/2018 1 Tennessee CoverRx List Run : 04/26/18 Dosage Form amiodarone HCl 200 MG TABLET ORAL 04/25/2018 0.16102 0.14405 11.8 hydralazine HCl 100 MG TABLET ORAL 04/25/2015 0.11390 0.10854 4.9 hydralazine HCl 25

More information

There have been no updates to the Aetna Better Health of MI formulary for February

There have been no updates to the Aetna Better Health of MI formulary for February AETNA BETTER HEALTH Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on April 1, 2018 Drug Name, Strength, Dosage Form BUTALBIT-ACETAMINOPHEN-CAFF CP CELECOXIB

More information

Commonwealth Care Alliance (Medicare-Medicaid Plan) One Care Plan

Commonwealth Care Alliance (Medicare-Medicaid Plan) One Care Plan 2018 List of Covered Drugs (Formulary) Commonwealth Care Alliance (Medicare-Medicaid Plan) One Care Plan 30 Winter Street Boston, MA 02108 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS

More information

ALLERGIC CONJUNCTIVITIS AGENTS

ALLERGIC CONJUNCTIVITIS AGENTS 2018 5 Tier Standard- Keystone First VIP Choice Document: 2018 Step Therapy Formulary ID: 18390 Last Updated: 04/2018 Effective Date: 05-01-2018 ALLERGIC CONJUNCTIVITIS AGENTS epinastine 0.05 % eye drops

More information

Formulary (Drug List)

Formulary (Drug List) Formulary (Drug List) PacificSource Community Solutions This list was updated on /5/07 Please Read: This document contains information about the drugs we cover on this plan. For a complete, up-to-date

More information

2014 Quantity Limits (QL) Criteria

2014 Quantity Limits (QL) Criteria 2014 Quantity Limits (QL) Criteria Certain drugs covered through your EmblemHealth Medicare HMO/PPO Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food

More information

TennCare Program TN MAC Price Change List As of: 03/30/2017

TennCare Program TN MAC Price Change List As of: 03/30/2017 1 TN List Run : 03/30/17 Old PRAZOSIN HCL 5 MG CAPSULE ORAL 03/29/2017 1.11209 1.12560 ( 1.2) CAPTOPRIL 12.5 MG TABLET ORAL 07/07/2015 1.07191 1.10416 ( 2.9) ISOSORBIDE DINITRATE 5 MG TABLET ORAL 03/29/2017

More information

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS ANTIDIABETIC AGENTS - MISCELLANEOUS Glyxambi 10 mg-5 mg tablet Glyxambi 25 mg-5 mg tablet Invokamet 150 mg-1,000 mg tablet Invokamet 150 mg-500 mg tablet Invokamet 50 mg-1,000 mg tablet Invokamet 50 mg-500

More information

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details 5-ASA DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum. 1 ANTIEMETICS

More information

ATYPICAL ANTIPSYCHOTICS

ATYPICAL ANTIPSYCHOTICS Step Therapy CareOregon 2018 Last Updated: 07/27/2018 ATYPICAL ANTIPSYCHOTICS Fanapt Fanapt Titration Pack Paliperidone Er Vraylar The following criteria applies to members who newly start on the drug:

More information

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release Updated 11/1/17 5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda

More information

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT NOVEMBER 30, 2010

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT NOVEMBER 30, 2010 IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201056 NOVEMBER 30, 2010 Changes to the Preferred Drug List Changes to the Preferred Drug List (PDL) were made at the November 19, 2010, Drug Utilization

More information

CONTENTS SECTION 1 SECTION

CONTENTS SECTION 1 SECTION CONTENTS SECTION 1 Foundations of Drug Therapy 1 CHAPTER 1 Introduction to Pharmacology 3 A Message to Students 3 Pharmacology and Drug Therapy 3 Understanding Grouping and Naming of Drugs 4 Prescription

More information

Texas Vendor Drug Program. Formulary Drug Index File Layout. Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018

Texas Vendor Drug Program. Formulary Drug Index File Layout. Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018 Texas Vendor Drug Program Formulary Drug Index File Layout Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018 The Vendor Drug Program provides a weekly update of resource data available for download

More information

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details AMANTADINE ER OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, EXTENDED RELEASE OSMOLEX ER 258 MG TABLET, PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS.

More information

Step Therapy Requirements. Effective: 1/1/2019

Step Therapy Requirements. Effective: 1/1/2019 Effective: 1/1/2019 Updated 1/2019 AMANTADINE ER Sharp Health Plan (HMO) OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED RELEASE PRIOR CLAIM FOR AMANTADINE

More information

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017 ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG FETZIMA CAPSULE

More information

STEP THERAPY CRITERIA

STEP THERAPY CRITERIA STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered under your medical or prescription

More information

UPDATE WellCare s New Jersey

UPDATE WellCare s New Jersey UPDATE WellCare s New Jersey Preferred Drug List July 13, 2015 Dear Provider: At the June 04, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes will be

More information

Drug List Oregon (OR) This formulary was updated on April 22, 2018.

Drug List Oregon (OR) This formulary was updated on April 22, 2018. 8 Oregon (OR) Drug List This formulary was updated on April, 8. Please Read: This document contains information about the drugs we cover in this plan. For a complete, up-to-date list of covered drugs,

More information

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details AMANTADINE ER OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, EXTENDED RELEASE OSMOLEX ER 258 MG TABLET, PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS.

More information

Rationale for Decision Excluded Generic OTC equivalent available (Flonase Allergy Relief) Medicare status (if differs)

Rationale for Decision Excluded Generic OTC equivalent available (Flonase Allergy Relief) Medicare status (if differs) BLUE SHIELD OF CALIFORNIA FIRST QUARTER 2015 FORMULARY AND MEDICATION POLICY UPDATES EFFECTIVE MARCH 19, 2015 The Blue Shield of California (BSC) Pharmacy and Therapeutics (P&T) Committee, consisting of

More information

ANTICONVULSANT STEP THERAPY

ANTICONVULSANT STEP THERAPY 2019 First Choice VIP Care Plus Formulary Document: 2019 Step Therapy Formulary ID: 19391 Last Updated: 2/2019 Effective Date: 03-01-2019 ANTICONVULSANT STEP THERAPY APTIOM 200 MG APTIOM 400 MG APTIOM

More information

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019 DPP4 INHIBITORS Janumet 50 mg-1,000 mg tablet Januvia 50 mg tablet Janumet 50 mg-500 mg tablet Onglyza 2.5 mg tablet Januvia 100 mg tablet Onglyza 5 mg tablet Januvia 25 mg tablet Tradjenta 5 mg tablet

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS APTIOM 200 MG TABLET APTIOM 400 MG TABLET APTIOM 600 MG TABLET APTIOM 800 MG TABLET BANZEL 200 MG TABLET BANZEL 40 MG/ML ORAL SUSPENSION BANZEL 400 MG TABLET FYCOMPA 0.5 MG/ML ORAL SUSPENSION

More information

Trusted Health Plan Formulary

Trusted Health Plan Formulary 2017 Trusted Health Plan Formulary Version 9, Effective 10/5/2017 Introduction... 6 The Trusted Health Plan Pharmacy and Therapeutics Committee (P&T)... 6 Notice...6 Preface...6 Product Selection Criteria...

More information

Step Therapy Requirements. Effective: 12/01/2016

Step Therapy Requirements. Effective: 12/01/2016 Effective: 12/01/2016 H2986_PD_049 Updated 11/2016 ALPHA 1-PROTEINASE INHIBITOR GLASSIA PRIOR CLAIM FOR ARALAST NP OR ZEMAIRA WITHIN THE PAST 120 DAYS. ANALGESICS, NARCOTICS KADIAN MORPHINE SULFATE ER

More information

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet DPP4 INHIBITORS Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet Januvia 50 mg tablet Onglyza 2.5 mg tablet Onglyza 5 mg tablet Tradjenta 5 mg tablet

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200 mg tablet Banzel 40 mg/ml oral suspension Banzel 400 mg tablet Fycompa 0.5 mg/ml oral suspension

More information

Removed from formulary. Removed from formulary. Added to formulary. Quanitity limit changed. Removed from formulary. Removed from formulary

Removed from formulary. Removed from formulary. Added to formulary. Quanitity limit changed. Removed from formulary. Removed from formulary AETNA BETTER HEALTH October 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on October 1, 2017 MIDAZOLAM HCL 5MG/ML VIAL MIDAZOLAM HCL 10 MG/2 ML

More information

LABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION

LABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION LABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION Added Prior Authorization 7/1/17 CORLANOR 5 MG TABLET Added Prior Authorization 7/1/17 CORLANOR 7.5 MG TABLET Added Prior Authorization 7/1/17

More information

Office of Medicaid Policy and Planning Over-the-Counter Drug Formulary ANALGESICS ANTACIDS ANTI-FLATULENTS

Office of Medicaid Policy and Planning Over-the-Counter Drug Formulary ANALGESICS ANTACIDS ANTI-FLATULENTS Acetaminophen 80mg/0.8mL Suspension Drops Acetaminophen 120mg Suppository Acetaminophen 160mg/5mL Suspension Acetaminophen 325mg Suppository Acetaminophen 325mg Tablet, Caplet, or Capsule Acetaminophen

More information

Emblem Medicaid 3Q18 Formulary Updates

Emblem Medicaid 3Q18 Formulary Updates ALKERAN 2 MG TABLET Removed from Formulary 7/9/2018 AMITIZA 24 MCG CAPSULES Removed from Formulary 7/9/2018 AMITIZA 8 MCG CAPSULE Removed from Formulary 7/9/2018 avo cream topical emulsion Removed from

More information

Tribute 2018 Formulary 2018 Quantity Limit Criteria

Tribute 2018 Formulary 2018 Quantity Limit Criteria APREPITANT Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil Oral Tablet 150, 200, 250, 50

More information

Tribute 2018 Formulary 2018 Quantity Limit Criteria

Tribute 2018 Formulary 2018 Quantity Limit Criteria APREPITANT Aprepitant ORAL CAPSULE 125, 40, 80 Aprepitant Oral CAPSULE 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil ORAL TABLET 150, 200, 250, 50

More information

FirstCarolinaCare Insurance Company. Step Therapy Requirements

FirstCarolinaCare Insurance Company. Step Therapy Requirements FirstCarolinaCare Insurance Company Step Therapy Requirements Effective: 12/01/2018 ANTICONVULSANTS APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG BANZEL 200 MG BANZEL 40 MG/ML ORAL SUSPENSION

More information

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E Santa Clara Family Health Plan Cal MediConnect Formulary List of Step Therapy Requirements Effective: 12/01/2018 13027.12E ANTICONVULSANTS APTIOM 200 MG TABLET APTIOM 400 MG TABLET APTIOM 600 MG TABLET

More information

Texas Vendor Drug Program. Formulary Delimited File Layout. April 26, 2017

Texas Vendor Drug Program. Formulary Delimited File Layout. April 26, 2017 Texas Vendor Drug Program Formulary Delimited File Layout April 26, 2017 The Vendor Drug Program provides a weekly update of resource data available for download from txvendordrug.com/resources/downloads.

More information

Provider update: Quarterly pharmacy formulary change notice

Provider update: Quarterly pharmacy formulary change notice Serving Hoosier Healthwise and Healthy Indiana Plan November 5, 2015 Provider update: Quarterly pharmacy formulary change notice Effective December 1, 2015, the preferred formulary changes detailed in

More information

Trusted Health Plan Formulary

Trusted Health Plan Formulary 2018 Trusted Health Plan Formulary Version 13; Effective: 2/10/2018 Introduction... 6 The Trusted Health Plan Pharmacy and Therapeutics Committee (P&T)... 6 Notice...6 Preface...6 Product Selection Criteria...

More information

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0. ANTI DIABETICS BYDUREON 2 MG SUBCUTANEOUS JANUVIA 25 MG TABLET EXTENDED RELEASE SUSPENSION JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET

More information

PDP Classic Formulary Addendum

PDP Classic Formulary Addendum PDP Classic Formulary Addendum The following medications have been added to the WellCare formulary as of March 2009. Drug Name Therapeutic Class Drug Tier Requirements/Limits Changes Made acetazolamide

More information

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies BlueCross BlueShield of South Carolina may add or remove drugs from the formulary during the year. If we remove drugs

More information

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY BENICAR 20 MG BENICAR 40 MG BENICAR 5

More information